One such example is the MYC gene, whose overexpression is responsible for many pathways important for tumourigenesis in several oncologic diseases, namely leukaemia, lung cancer, endometrial cancer, prostate cancer, glioma, and pancreatic ductal adenocarcinoma [99,106,107,108,109,110]. This evidence concerns the gene MYC and leukemia.